Cardiovascular Risk

AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images

Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors

Evaluation of Cardiovascular Risks Among the Participants of the ESC Congress 2025

Interdisciplinary Program to Improve Lifestyle in Chronic Pathology: Alt Pirineu Aran in Fit (APA-FIT)

Cf-PWV and TyG Index Study

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.

Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Impact of the Corrie Lipids Digital Health Program on Lipid Optimization

Guideline Adherence in Dyslipidemia With Clinical Decision Support

Digital Prevention Program With Telephonic Coaching

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)

Canagliflozin and Myocardial Fibrosis

Time Restricted Eating in Survivors Trial 2.0

A Community Cardiovascular Disease Risk Reduction Program in Older Adults Engaged in Congregate Nutrition Services (CAN-DO)

Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause).

Dose-Response to Resistance Exercise on Cardiovascular Health

Study of the Effects of Yerba Mate on Cardiometabolic Health